DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT06382168 · RECRUITING

Trial details

NCT number: NCT06382168
Sponsor: Delta-Fly Pharma, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute

Start date: 2024-06-12
Primary completion: 2026-03-31
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.